Rayos Medicinal: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Rayos Medicinal
Largest movements
- Cash +€301,924
up €301,924 (+121%), from €249,293 to €551,217
mainly Net result for the year (+€301,561) and Tax, wage and social debts (+€63,833)
- Receivables within one year +€32,655
up €32,655 (+26.3%), from €124,250 to €156,905
of which Trade receivables: +€32,753
- Tangible fixed assets +€26,097
up €26,097 (+702%), from €3,719 to €29,816
of which Other tangible fixed assets: +€27,500
- Deferred charges and accrued income +€7,654
up €7,654 (+2,169%), from €353 to €8,007
- Reserves +€301,561
up €301,561 (+105%), from €288,568 to €590,129
- Tax, wage and social debts +€63,833
up €63,833 (+73.8%), from €86,507 to €150,340
- Gross operating margin +€161,486
up €161,486 (+67.9%), from €237,699 to €399,185
- Taxes +€40,334
up €40,334 (+72.9%), from €55,361 to €95,695
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €377,615 | €745,945 | +€368,329 | +97.5% |
| Fixed assets | 21/28 | €3,719 | €29,816 | +€26,097 | +702% |
| Tangible fixed assets | 22/27 | €3,719 | €29,816 | +€26,097 | +702% |
| Furniture and vehicles | 24 | €3,719 | €2,316 | -€1,403 | -37.7% |
| Other tangible fixed assets | 26 | - | €27,500 | +€27,500 | |
| Current assets | 29/58 | €373,896 | €716,129 | +€342,233 | +91.5% |
| Amounts receivable within one year | 40/41 | €124,250 | €156,905 | +€32,655 | +26.3% |
| Trade receivables | 40 | €118,682 | €151,435 | +€32,753 | +27.6% |
| Other amounts receivable | 41 | €5,568 | €5,470 | -€98 | -1.8% |
| Current investments | 50/53 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €249,293 | €551,217 | +€301,924 | +121% |
| Deferred charges and accrued income | 490/1 | €353 | €8,007 | +€7,654 | +2,169% |
| Total equity and liabilities | 10/49 | €377,615 | €745,945 | +€368,329 | +97.5% |
| Equity | 10/15 | €289,568 | €591,129 | +€301,561 | +104% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €288,568 | €590,129 | +€301,561 | +105% |
| Distributable reserves | 133 | €288,568 | €590,129 | +€301,561 | +105% |
| Amounts payable | 17/49 | €88,047 | €154,816 | +€66,769 | +75.8% |
| Amounts payable within one year | 42/48 | €88,047 | €154,816 | +€66,769 | +75.8% |
| Financial debts | 43 | €738 | €0 | -€738 | -100% |
| Credit institutions | 430/8 | €738 | €0 | -€738 | -100% |
| Trade debts | 44 | €803 | €4,477 | +€3,674 | +458% |
| Suppliers | 440/4 | €803 | €4,477 | +€3,674 | +458% |
| Taxes, remuneration and social security | 45 | €86,507 | €150,340 | +€63,833 | +73.8% |
| Taxes | 450/3 | €86,507 | €150,340 | +€63,833 | +73.8% |
| Other amounts payable | 47/48 | €0 | - | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,388 | €1,403 | +€15 | +1.1% |
| Other operating charges | 640/8 | €827 | €702 | -€124 | -15.0% |
| Gross operating margin | 9900 | €237,699 | €399,185 | +€161,486 | +67.9% |
| Operating profit (loss) | 9901 | €235,485 | €397,079 | +€161,595 | +68.6% |
| Financial income | 75/76B | €1,351 | €902 | -€449 | -33.2% |
| Recurring financial income | 75 | €1,351 | €902 | -€449 | -33.2% |
| Financial charges | 65/66B | €753 | €726 | -€27 | -3.6% |
| Recurring financial charges | 65 | €753 | €726 | -€27 | -3.6% |
| Profit (loss) for the period before taxes | 9903 | €236,083 | €397,256 | +€161,173 | +68.3% |
| Income taxes | 67/77 | €55,361 | €95,695 | +€40,334 | +72.9% |
| Profit (loss) for the period | 9904 | €180,721 | €301,561 | +€120,839 | +66.9% |
| Profit (loss) for the period to be appropriated | 9905 | €180,721 | €301,561 | +€120,839 | +66.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.